Overview

Levetiracetam in Post-Traumatic Stress Disorder

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the short-term efficacy and safety of levetiracetam in post-traumatic stress disorder (PTSD) and to evaluate continuation effects of levetiracetam in preventing PTSD relapse. The hypothesis is that levetiracetam will be safe and effective in preventing relapse of PTSD.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam